Zepbound Market Impact - Search News

Order byBest matchMost fresh

News

Wegovy, Zepbound and Lilly

Zepbound trims more belly fat than Wegovy, study shows

The obesity drug helped people trim about two inches more off their waists than Wegovy in the first head-to-head study of the rival medicines.

Continue reading

· 3d · on MSN

Lilly’s Zepbound Trims More Belly Fat Than Novo’s Wegovy

Eli Lilly's Zepbound outperforms Novo Nordisk's Wegovy for weight loss in trial

4d

Why Patients Are Being Forced to Switch to a 2nd-Choice Obesity Drug

CVS Caremark decided to stop offering Zepbound in favor of Wegovy for weight loss. It’s the latest example of limits imposed ...

1d

Patients Are Left With Few Options as GLP-1 Copycats Disappear

With the active ingredients in drugs like Ozempic and Zepbound no longer in shortage, access to medicine for millions who had ...

9d

Beyond Valuation Ratios: 3 Undervalued Stocks To Buy In May 2025

Looking for undervalued stocks? Check out three top undervalued stocks to buy now in May, 2025 to boost your portfolio.

13don MSN

Eli Lilly downplays CVS move to drop Zepbound coverage, shares plunge

Eli Lilly on Thursday downplayed CVS Health's decision to drop the company's obesity drug Zepbound from some lists of ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results